Combined High Resistin and EGFR Expression Predicts a Poor Prognosis in Breast Cancer

Figure 1

Resistin and EGFR protein expression was analyzed in ER-positive/ER-negative, HER-positive/HER-negative, TNBC/non-TNBC human breast cancer tissues by immunohistochemical staining. Cancer tissue microarrays were immune-stained with anti-resistin, anti-EGFR, anti-ER, and anti-HER2 antibodies. Representative images of stained tissues are shown.